Back to RecallTracker
Health Canada Health products

OPTIMARK (gadoversetamide injection) – Association with Nephrogenic Systemic Fibrosis (NSF) in Patients with Renal Impairment – For the Public

Issued January 12, 2010
Issue
Hazard description
Product safety